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CytotoxicityAbstract Elevation of acetylcholinesterase enzyme (AChE) has been reported to be implicated in
the etiology of Alzheimer disease (AD). One of the encouraged strategies to ﬁght AD is the
plant-derived inhibitors. Amaryllidaceae species are enriched source of alkaloids. The inhibitory
properties of roots and bulbs of Pancratium maritimum L. against AChE have been previously
reported. In the present study, the ﬂowers of the wild Egyptian P. maritimum were subjected to
screening assays to evaluate its potency as inhibitor to AChE. Besides, its antioxidant and cytotoxic
properties were also addressed. The acetylcholinesterase inhibitory properties of P. maritimum; total
extract and its alkaloid mixture were examined using Ellman’s assay. The direct antioxidant
examination was carried out using DPPH assay whereas the indirect was monitored by the ability
to protect Hepa1c1c7 cells against the induced cytotoxicity produced by tert-butyl hydroperoxide
(TBHP). The cytotoxic effect of the total extract and crude alkaloid mixture was evaluated against
the human liver hepatoma cell line (HepG2). P. maritimum ﬂowers showed signiﬁcant inhibitory
activity against AChE. The potency of the alkaloid mixture, representing 5.0% of the ﬂowers weight
(IC50; 22.02 ± 0.59 lg/ml) was about fourfold of its total extract (IC50; 97.67 ± 4.06 lg/ml). The
total extract was able to protect about 33.4% of Hepa1c1c7 against the induced intoxication that
carried by TBHP rather than the alkaloid mixture. Weak antioxidant and cytotoxic activities were
recorded by both examined samples. Flowers of the Egyptian P. maritimum L. could be an enriched
source of AChE inhibitors.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Alzheimer disease (AD) is a neurodegenerative disorder that
progressively attacks the cognitive function, mainly of elders
and eventually causing death. Medication and extra burden
Figure 1 Pancratium maritimum L. Flowers, The Mediterranean
cost, Matrouh Governorate, Egypt.
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when caregivers are not volunteers. Elevation of acetyl-
cholinesterase enzyme (AChE) has been reported as a hall
mark in the etiology of the disease encouraging several trials
of seeking inhibitors against the accused enzyme.1
One of the recommended inhibitors of AChE is the
alkaloids-class of phytochemical compounds. Amaryllidaceae
species are enriched source of the concerned alkaloids sec-
ondary metabolites. Pancratium maritimum L. belongs to
Amaryllidaceae where the inhibitory properties of its roots
and bulbs against AChE were reported and attributed to their
contents of alkaloids.2,3 Galanthamine; the FDA-approved
potent medication to reduce the mild and moderate symptoms
of AD was reported to present as a predominant alkaloid in
P. maritimum L. growing in Egypt. The present study aimed
to investigate the ability of the wild Egyptian P. maritimum
ﬂowers to inhibit the AChE. Besides, test of the antioxidant
properties, concerning both direct against the free radical
2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and the indirect
by monitoring its ability to protect Hepa1c1c7 cells against the
induced intoxication produced by tert-butyl hydroperoxide
(TBHP). Moreover, the cytotoxic effect against human liver
hepatoma cell line (HepG2) was also examined.2. Materials and methods
2.1. Plant material
The fresh ﬂowers, of the wild plant, P. maritimum, were
collected in August, 2011, from Matrouh Governorate, on
the Mediterranean cost, Egypt (Fig. 1). The plant was kindly
identiﬁed by Dr. M. Gibali, Senior Botanist, Faculty of
Sciences, Cairo University. Voucher specimen (BUPD24) is
deposited in the Pharmacognosy Department, Faculty of
Pharmacy, Beni-Suef University, Egypt.
2.1.1. Preparation of natural samples for the biological study
Fresh ﬂowers of P. maritimum (100 g) were exhaustively
extracted with 70% EtOH. The combined solvents were
evaporated under reduced pressure, to dryness. The obtained
extract was weighed and stored in a dark container at
20 C till biological study. Portion of the extract was taken
to prepare the crude alkaloid mixture following the method
previously described.4 The obtained alkaloid mixture was also
stored in the dark and at low temperatures till biological study.
All chemicals used during the work were of analytical grade.
2.2. Methods
2.2.1. Phytochemical screening of P. maritimum L. ﬂowers
The total 70% ethanol extract (Total extract) of P. maritimum
ﬂowers was subjected to phytochemical screening for various
phytochemicals such as alkaloids, ﬂavonoids, carbohydrates,
phenolic compounds, sterols and triterpenoids.5–8
2.2.2. Biological evaluation of P. maritimum ﬂowers
2.2.2.1. Acetylcholinesterase inhibition (Ellman’s assay). The
acetylcholinesterase inhibitory properties of P. maritimum,
total extract and its alkaloid mixture were examined using
Ellman’s assay. The assay is based on the reported methodby Ali et al.9 which is modiﬁed from the previously published
literature.1,10 Brieﬂy, the total extract and its alkaloid mixture
(25 ll of 10 · of ﬁnal concentrations in DMSO) was dispensed
in triplicate onto 96 well microplate and mixed with 200 ll of
Ellman’s mixture containing 10 mM Tris–HCl, pH 8, 0.1%
bovine serum albumin (BSA, fraction V), 1.5 mM acetylthio-
choline iodide (ATCI, Sigma–Aldrich, Germany) and 3 mM
5,50-dithio-bis-(2-nitrobenzoic acid) (DTNB, Sigma–Aldrich,
Germany). The control wells contained the vehicle (DMSO)
where Donepezil hydrochloride (Aricept, Pﬁzer) was routine-
ly used as standard inhibitor of AChE. The reaction was start-
ed after the addition of enzyme solution (25 ll, 0.1 U/ml).
Autohydrolysis of the substrate was corrected by replacing
the enzyme with 25 ll of enzyme buffer (10 mM Tris–HCl,
pH 8, containing 0.1% BSA). The enzymatic activity was mon-
itored kinetically after 5 min of incubation with the enzyme,
every 30 s intervals for 3 min (linear reaction) at 30 C and
wave length 450 nm. The enzyme rate was calculated from
the slope of the curve of absorbance change versus time.
2.2.2.2. Direct antioxidant assay (radical scavenging). The
assay used in the present study was based on a modiﬁed pro-
cedure11 which is based essentially on the previously published
literature.12
Brieﬂy, the total extract and its alkaloid mixture were
prepared in DMSO as 10 · stocks from each test concentration.
As strategy, radical scavenging activities equal to or higher than
50% at 100 lg/ml in a preliminary screen were further tested
and IC50 (concentration of the extract/compound producing
50% scavenging of DPPH radicals) determined using nonlinear
regression analysis of the dose-% AA relationship Eq. (1).
% Antioxidant activity ð%AAÞ
¼ 100 ½OD540 nm ðblankÞ OD540 nm ðsampleÞ
OD540 ðblankÞ ð1Þ
The OD in the equation represents the measured optical
density.
Quercetin was tested in the assay as the positive control.
The extract and its alkaloid mixture stock solutions (20 ll/
well) were dispensed in triplicate onto 96-well plate (ﬂat-
bottomed, Greiner bio one, Belgium). The assay was started
with the addition of DPPH reagent (0.004% wt/v) in
methanol, 180 ll/well. Appropriate blanks were prepared
Table 1 IC50 determination of the total extract and alkaloid
mixture of P. maritimum ﬂowers as inhibitors to AChE.a
Examined sample IC50 of inhibiting AChE (m ± SEM)
b
Total 70% EtOH extract 97.67 ± 4.06 lg/ml
Crude alkaloid mixture 22.02 ± 0.59 lg/ml
Aricept 1.14 ± 0.05 lM
a The results represent the average of three replicates obtained
from three independent experiments.
b AChE: acetylcholinesterase enzyme; m: Mean; SEM: standard
error of mean.
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DPPH reagent to get rid of any inherent solvent activity.
Negative controls were also run in parallel to correct for any
non-DPPH absorbance by colored extracts at the test
wavelength. The plate was immediately shaken for 30 s and
incubated in the dark for 30 min. at room temperature. The
remaining DPPH was measured in the microplate reader at
540 nm. The percentage of antioxidant activity (%AA) was
calculated relative to vehicle control according the equation.
2.2.2.3. Indirect antioxidant assay in Murine hepatoma cell line
Hepa1c1c7). Monolayer culture of Hepa1c1c7 (generously
provided by Professor M.S. Denison, University of
California, USA) was maintained in a-MEM supplemented
with 10% FBS, 2 mM L-glutamine, 250 ng/ml Amphotericin
B. Cells were grown in 75-cm2 tissue culture ﬂasks at 37 C
in a 5% CO2 humidiﬁed environment using CO2 incubator
(CERTOMAT CS-20). Cells were routinely sub-cultured at
about 75–85% conﬂuence using Trypsin/EDTA solution
(Lonza, Belgium) containing 0.5 g/L Trypsin and 0.2 g/L.
(All culture reagents were purchased from Lonza, Belgium).
Hepa1c1c7 cells were seeded onto 24-well culture plates
(Greiner Bio-one, Germany) as 0.2 · 104 cells/well.
Exponentially growing monolayers (at about 75–85% conﬂu-
ency) were treated with DMSO (vehicle control), total extract
or the alkaloid mixture. The preliminary screening was based
on dilution of the plant samples stock solution in DMSO
(200·) in culture medium to give ﬁnal concentration of
100 lg/ml of the extract and 10 lg/ml of the fraction.
Quercetin as standard antioxidant was examined in parallel
at 4 lg/ml. Treated plates were incubated for 24 h prior to
the exposure to 125 lM of TBHP as induced dose for oxidative
cytotoxicity. The Neutral Red Uptake (NRU) Assay13 was
performed as the endpoint for cell viability measurement to
monitor the cytoprotection produced by tested samples.
2.2.2.4. Cytotoxicity assay against Human hepatocellular car-
cinoma cell line (HepG2). HepG2, (ATCC) cells were main-
tained as monolayer cultures in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Lonza, Belgium) supplemented with 10%
FBS, 4 mM L-glutamine, 100 U penicillin and 100 lg/ml strep-
tomycin sulfate). Cells were incubated and routinely sub-cul-
tured as carried with Hepa1c1c7 cultures.
HepG2 cells were seeded onto 24-well culture plates
(Greiner Bio-one, Germany) as 0.15 · 104 cells/well.
Exponentially growing mono layers were treated separately
with the total extract and alkaloid mixture as performed with
the indirect antioxidant assay. A reference cytotoxic
compound; Adriamycin-Doxorubicin (Pﬁzer) was used as a
positive control for cytotoxicity. Treated plates were incubated
for 48 h prior to evaluation of the produced cytotoxicity using
NRU. At the end of the incubation time, the culture medium
was aspirated from the wells and replaced with 0.4 ml
Neutral red (Sigma, cat. No. N4638) solution (40 lg/ml).
The plates were then incubated for 2 h. Every well was then
washed with Dulbecco’s phosphate buffered saline (DPBS).
Fixative solution (1% (v/v) glacial acetic acid in 50% ethanol)
was then added to every well. The plates were shaken for
10 min. to extract the cell-retained dye. Aliquots of the
Desorbed dye solution (100 ll) were then transferred onto
wells of 96-well plates. Triplicate absorbances were then read
on Fluostar Optima microplate reader (BMG LABTECH,Germany) at 540 nm. Cell free blank was used for background
correction of the absorbance. The viability was expressed as a
percentage relative to the solvent control absorbance value
after subtracting the contribution from cell-free blank.
2.2.3. Statistical analysis
Regression analysis was used to determine IC50 values using the
concentration-activity relationship. All data were represented
as the mean value of triplicate absorbance measurements.
3. Results and discussion
3.1. Yield and phytochemical screening
The total extract yielded 7.5 g obtained from 100 g fresh ﬂow-
ers. The prepared crude alkaloid mixture was about 67% of
the total extract (two thirds) and 5% of the ﬂowers fresh
weight. The phytochemical screening of the total extract
revealed the presence of alkaloids and ﬂavonoids as major
components, phenolic compounds, carbohydrates and/or
glycosides and traces of sterols and/or triterpenes.
3.2. Biological screening
3.2.1. Anti-cholinesterase activity using Ellman’s assay
The examined samples; total extract and crude alkaloid
mixture, of P. maritimum ﬂowers produced 100% inhibition
of AChE in a preliminary experiment at 1000 lg/ml (single
concentration). Both samples were subjected to further investi-
gation in order to determine their IC50 against AChE. The
results are represented in Table 1. The IC50 value of the alka-
loid mixture was reduced about 4.4-fold (22.02 ± 0.59 lg/ml)
than the IC50 of the total extract (97.67 ± 4.06 lg/ml).
Different types of alkaloids were identiﬁed in the P. maritimum
growing in Egypt such as Tazettine, galanthamine and its
derivatives, Lycorine, Crinine and its derivatives. Some of
them could contribute to the potent inhibition effect of the
extract; lycorine, maritidine, lycoramine, and galanthamine4,14
that could be synergistically interacting to inhibit the accused
enzyme, AChE.3 Galanthamine is the potent agent of
Razadyne. It was approved by FDA15 to treat mild to mod-
erate symptoms concomitant to Alzheimer’s disease. Flowers
of P. maritimum growing in Egypt contain Galanthamine
and N-Demethygalanthamine representing about 33.7% of
the alkaloid mixture4 equivalent to 1.65% of the plant ﬂowers
weight, so ﬂowers could be a good source for preparing
Galanthamine. The results of AChE inhibitions in the present
study support, in part the traditional uses of Amaryllidaceae
Table 2 Antioxidant activity and cytotoxicity results of P. maritimum ﬂowers.a
Examined sample Anti-oxidant properties Cytotoxicity properties
% DPPH scavenging % Protection of Hepa1c1c7 % Toxicity of HepG2
Total 70% EtOH extract 12.7 (100 lg/ml) 33.4 (100 lg/ml) 52.5 (200 lg/ml)
Crude alkaloid mixture 14.1 (100 lg/ml) 1.4 (5 lg/ml) 29.2 (5 lg/ml)
Quercetin 95.6 (10 lg/ml) 77.2 (4 lg/ml) –
Doxorubicin – – 80.0 (5 lg/ml)
a The % protection was calculated by subtracting the % viability recorded by the treated Hepa1c1c7 monolayers with 125 lM TBHP (3.5%)
from the % viability recorded from treated monolayers with the total extract, alkaloid mixture or quercetin.
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gravis, myopathy and diseases of the nervous system.3
3.2.2. Direct and indirect anti-oxidant activity
P. maritimum ﬂowers could not be a promising source of anti-
oxidants where 615% radical scavenging was recorded by
both examined samples at single concentration (100 lg/ml).
However, the total extract was able to protect about 33.4%
of Hepa1c1c7 against the induced intoxication that was pro-
duced by TBHP (Table 2).
The implication of the oxidative stress in AD patho-
genesis was reported.16 A study that investigated a group
of plant species attributed their traditional uses in the
remedy of AD symptoms to different properties including
antioxidant or AChE inhibitions.9 Our results emphasize,
the ability of the P. maritimum against AD toward the inhi-
bition of the AChE rather than the antioxidation activity.
However, this protection power of the total extract could
be attributed to its contents of ﬂavonoids and/or phenolic
compounds.
3.2.3. Cytotoxicity against HepG2
Both of the total extract and alkaloid mixture showed weak
cytotoxicity (52.5% at and 29.2%) against HepG2 at single
screening concentration; 200 lg/ml and 5 lg/ml, respectively
(Table 2). However, we could attribute, in part the produced
cytotoxicity to alkaloids such as pancratistatin and/or 3-caf-
feoylquinic acid methyl ester. Both alkaloids were previously
isolated from the ﬂowers17 and showed a potent cytotoxic
effect against Hela cells. However, the cytotoxic results of
P. maritimum could be considered in future risk assessment
of monitoring the concerned plant against AD.4. Conclusion
Flowers of the Egyptian P. maritimum could be an enriched
source of AChE inhibitors. To the best of our knowledge, this
is the ﬁrst report that investigated the antioxidant ability of the
wild P. maritimum L. ﬂowers to protect the induced
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